# US 2022/0031793 A1 · Neuroprotection and neuroregeneration by pterostilbene and compositions thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031793 A1
- Document ID: US20220031793A1
- Status: Published application
- Kind: A1
- Application number: 17/387,158
- Filed: 2021-07-28
- Published: 2022-02-03
- Earliest claimed: 2020-07-28
- Assignees: Therapeutic Solutions International, Inc.
- Applicants: Therapeutic Solutions International, Inc.
- Inventors: Thomas E. ICHIM; Timothy G. DIXON; James VELTMEYER
- Web page: https://patentgrep.com/patent/US20220031793A1

## CPC

- A61K 36/82: Theaceae (Tea family), e.g. camellia
- A61K 31/09: having two or more such linkages
- A61K 31/122: having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K 31/26: Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
- A61K 31/353: 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K 36/31: Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K 36/45: Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
- A61K 36/71: Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Disclosed are means, compositions of matter, and protocols useful for neuroprotection and neuroregeneration. In one embodiment the invention provides administration of pterostilbene alone or in combination with other ingredients to induce neuroprotection and/or neuroregeneration. The invention teaches protection/regeneration in conditions associated with neurological inflammation and/or other congenital or acquired neurodegenerative diseases.

## Claims

### Claim 1

A method of protecting from damage and/or regenerating a neurological tissue comprising administration of pterostilbene, and/or Green Tea and/or extract thereof, and/or Blueberry and/or extract thereof; c) Nigella Sativa and/or extract thereof; and d) broccoli and/or extract thereof.

### Claim 2 (depends on 1)

The method of claim 1, wherein said neurological protection is inhibition of neuronal apoptosis.

### Claim 3 (depends on 1)

The method of claim 1, wherein said neurological protection is inhibition of neuronal dysfunction.

### Claim 4 (depends on 1)

The method of claim 1, wherein said neurological protection is inhibition of neuronal excitotoxicity.

### Claim 5 (depends on 1)

The method of claim 1, wherein said neurological protection is inhibition of neuronal oxidative stress.

### Claim 6 (depends on 1)

The method of claim 1, wherein said neurological protection is upregulation of bcl-2.

### Claim 7 (depends on 1)

The method of claim 1, wherein said neurological protection is downregulation of fas ligand.

### Claim 8 (depends on 1)

The method of claim 1, wherein said neurological protection is downregulation of fas.

### Claim 9 (depends on 1)

The method of claim 1, wherein said regeneration of said neurological tissue comprises stimulation of axonal re-connections.

### Claim 10 (depends on 1)

The method of claim 1, wherein said regeneration of said neurological tissue comprises stimulation of proliferation of neural progenitor cells.

### Claim 11 (depends on 10)

The method of claim 10, wherein said neural progenitor cells are endogenous.

### Claim 12 (depends on 10)

The method of claim 10, wherein said neural progenitor cells are exogenous.

### Claim 13 (depends on 11)

The method of claim 11, wherein said endogenous neural progenitor cells are originating from the subventricular zone.

### Claim 14 (depends on 11)

The method of claim 11, wherein said endogenous neural progenitor cells are originating from the dentate gyrus of the hippocampus.

### Claim 15 (depends on 1)

The method of claim 1, wherein said green tea extract is epigallocatechin-3-gallate or an analogue thereof.

### Claim 16 (depends on 1)

The method of claim 1, wherein said blueberry extract is pterostilebene or an analogue thereof.

### Claim 17 (depends on 1)

The method of claim 1, wherein said Nigella Sativa extract is thymoquinone or an analogue thereof.

### Claim 18 (depends on 1)

The method of claim 1, wherein said broccoli extract is sulforaphane or an analogue thereof.

### Claim 19 (depends on 1)

The method of claim 1, wherein said neurological damage is COVID-19 associated.
